Abstract
A patient with metastatic placental site trophoblastic tumor is presented. Her treatment included several aggressive chemotherapeutic regimens. In this patient, the clinical course and assays of beta-hCG (beta fragment of human chorionic gonadotropin) correlated with her response to these treatments.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chorionic Gonadotropin / analysis
-
Cyclophosphamide / therapeutic use
-
Dactinomycin / therapeutic use
-
Female
-
Humans
-
Methotrexate / therapeutic use
-
Placenta Diseases / drug therapy*
-
Placenta Diseases / mortality
-
Placenta Diseases / pathology
-
Pregnancy
-
Survival
-
Tomography, X-Ray Computed
-
Trophoblastic Neoplasms / drug therapy
-
Trophoblastic Neoplasms / pathology
-
Trophoblastic Neoplasms / secondary*
Substances
-
Chorionic Gonadotropin
-
Dactinomycin
-
Cyclophosphamide
-
Methotrexate